当前位置:首页 - 行情中心 - *ST生物(000504) - 财务分析 - 现金流量表

*ST生物

(000504)

  

流通市值:29.49亿  总市值:29.57亿
流通股本:3.29亿   总股本:3.30亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金129,067,161.4678,890,097.0546,856,325.03230,653,967.3
  收到的税费返还1,154,692.19316,457.291,085.69184,688.22
  收到其他与经营活动有关的现金7,412,630.734,701,244.191,450,200.6111,168,978.84
  经营活动现金流入小计137,634,484.3883,907,798.5348,307,611.33242,007,634.36
  购买商品、接受劳务支付的现金32,055,958.3515,324,423.5910,938,151.81126,094,241.44
  支付给职工以及为职工支付的现金45,541,330.0435,670,965.2318,832,482.5970,218,101.14
  支付的各项税费11,243,358.519,596,529.295,943,535.0410,896,134.08
  支付其他与经营活动有关的现金31,468,952.5426,276,381.413,418,734.1630,005,574.85
  经营活动现金流出小计120,309,599.4486,868,299.5149,132,903.6237,214,051.51
  经营活动产生的现金流量净额17,324,884.94-2,960,500.98-825,292.274,793,582.85
二、投资活动产生的现金流量:
  收回投资收到的现金105,000,00040,229,390.4220.95192,907,473.68
  取得投资收益收到的现金5,328,704.213,191,627.441,578,082.195,594,383.55
  处置固定资产、无形资产和其他长期资产收回的现金净额17,50017,5005,0001,471.81
  收到的其他与投资活动有关的现金---2,526,523.35
  投资活动现金流入小计110,346,204.2143,438,517.841,583,303.14201,029,852.39
  购建固定资产、无形资产和其他长期资产支付的现金813,823.2570,200.1226,89018,262,796.78
  投资支付的现金105,000,000105,000,00065,000,000291,100,000
  取得子公司及其他营业单位支付的现金61,225,585.03---
  投资活动现金流出小计167,039,408.23105,570,200.165,226,890309,362,796.78
  投资活动产生的现金流量净额-56,693,204.02-62,131,682.26-63,643,586.86-108,332,944.39
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,250,000---
  取得借款收到的现金---18,000,000
  筹资活动现金流入平衡项目0--0
  筹资活动现金流入小计1,250,000--18,000,000
  偿还债务支付的现金1,000,000500,000500,00036,000,000
  分配股利、利润或偿付利息支付的现金2,034,725.32393,322.53314,419.74931,456.23
  支付其他与筹资活动有关的现金3,559,542.441,398,259.5673,951.95163,977,151.29
  筹资活动现金流出小计6,594,267.762,291,582.031,488,371.69200,908,607.52
  筹资活动产生的现金流量净额-5,344,267.76-2,291,582.03-1,488,371.69-182,908,607.52
四、汇率变动对现金及现金等价物的影响-11.45-11.45-40.59
五、现金及现金等价物净增加额-44,712,598.29-67,383,776.72-65,957,250.82-286,447,928.47
  加:期初现金及现金等价物余额207,333,146.93207,333,146.93207,333,146.93493,781,075.4
  期末现金及现金等价物余额162,620,548.64139,949,370.21141,375,896.11207,333,146.93
补充资料:
  净利润--14,062,869.87--23,925,602.31
  资产减值准备-4,167,695.97-22,857,355.54
  固定资产和投资性房地产折旧-1,241,171.78-2,477,993.74
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-1,241,171.78-2,477,993.74
  无形资产摊销-107,459.48-68,879.32
  长期待摊费用摊销-5,068,149.28-12,179,833.42
  处置固定资产、无形资产和其他长期资产的损失--32,482.62--155,702.85
  公允价值变动损失-145,895-6,629
  财务费用--217,576.42-1,462,410.54
  投资损失--3,416,948.57--3,689,457.92
  递延所得税--798,625.97--904,850.68
  其中:递延所得税资产减少--734,523.31--806,033.31
    递延所得税负债增加--64,102.66--98,817.37
  存货的减少-15,867,341.5--25,411,464.52
  经营性应收项目的减少--65,335,672.95--37,379,254.33
  经营性应付项目的增加-52,604,665.94-54,044,521.14
  现金的期末余额-139,949,370.21-207,333,146.93
  减:现金的期初余额-207,333,146.93-493,781,075.4
  现金及现金等价物的净增加额--67,383,776.72--286,447,928.47
公告日期2025-10-272025-08-282025-04-292025-04-29
审计意见(境内)标准无保留意见
TOP↑